: Three DNA polymorphisms (XbaI, EcoRI, and Ins/Del) of the apolipoprotein B (APOB) gene and the CfoI polymorphism of the APOE gene were investigated in a sample of 96 Cayapa Indians from Ecuador. The frequencies of the X + (0.182), R + (1.000), and Del alleles (0.432) at the three APOB sites were found to be higher than and to differ significantly from those reported for East Asians. No comparisons could be made between the Cayapa and other native Americans because of the lack of data on these sites. We observed in our sample that, like native American populations but unlike East Asians, the APOE allele frequencies were characterized by the absence of the APOE*2 allele and by a high frequency of the APOE*4 allele (0.280). Besides a probabl...
Genetic variation at three apolipoprotein loci (APOA4, APOH, and APOE) has been examined in nine end...
One-hundred sixty-four Cayapa Indians living in the Esmeraldas Province (northwest Ecuador) were stu...
Genetic factors can determine the high variability observed in response to lipid-lowering therapy w...
Three DNA polymorphisms (XbaI, EcoRI, and Ins/Del) of the apolipoprotein B (APOB) gene and the CfoI ...
Three DNA polymorphisms (Xbal, EcoRl, and Ins/Del) of the apolipoprotein B (APOB) gene and the Cfol ...
Using isoelectric focusing and immunoblotting techniques, we screened 96 serum samples from Yanomami...
The genetic variation at the Apolipoprotein E locus (APOE) is an important determinant of plasma lip...
Three apolipoprotein B restriction fragment length polymorphisms (RFLPs) (Xbal, Mspl, and £coRI) and...
Abstract. The genetic variation at the Apolipoprotein E locus (APOE) is an important determinant of ...
We report the distribution of the APOB signal peptide polymorphism in 5 native populations of South ...
Three polymorphisms (XbaI, EcoRI, and Ins /Del) of the apolipoprotein B (APOB) gene and the polymorp...
A tribal aboriginal community, the Mowanjum, from the Kimberley region in Western Australia has been...
Mexico has approximately 100 million inhabitants. Most of the urban Mexican population has been cons...
Three polymorphisms (XbaI, EcoRI, and Ins /Del) of the apolipoprotein B (APOB) gene and the polymorp...
Mexico has approximately 100 million inhabitants. Most of the urban Mexican population has been cons...
Genetic variation at three apolipoprotein loci (APOA4, APOH, and APOE) has been examined in nine end...
One-hundred sixty-four Cayapa Indians living in the Esmeraldas Province (northwest Ecuador) were stu...
Genetic factors can determine the high variability observed in response to lipid-lowering therapy w...
Three DNA polymorphisms (XbaI, EcoRI, and Ins/Del) of the apolipoprotein B (APOB) gene and the CfoI ...
Three DNA polymorphisms (Xbal, EcoRl, and Ins/Del) of the apolipoprotein B (APOB) gene and the Cfol ...
Using isoelectric focusing and immunoblotting techniques, we screened 96 serum samples from Yanomami...
The genetic variation at the Apolipoprotein E locus (APOE) is an important determinant of plasma lip...
Three apolipoprotein B restriction fragment length polymorphisms (RFLPs) (Xbal, Mspl, and £coRI) and...
Abstract. The genetic variation at the Apolipoprotein E locus (APOE) is an important determinant of ...
We report the distribution of the APOB signal peptide polymorphism in 5 native populations of South ...
Three polymorphisms (XbaI, EcoRI, and Ins /Del) of the apolipoprotein B (APOB) gene and the polymorp...
A tribal aboriginal community, the Mowanjum, from the Kimberley region in Western Australia has been...
Mexico has approximately 100 million inhabitants. Most of the urban Mexican population has been cons...
Three polymorphisms (XbaI, EcoRI, and Ins /Del) of the apolipoprotein B (APOB) gene and the polymorp...
Mexico has approximately 100 million inhabitants. Most of the urban Mexican population has been cons...
Genetic variation at three apolipoprotein loci (APOA4, APOH, and APOE) has been examined in nine end...
One-hundred sixty-four Cayapa Indians living in the Esmeraldas Province (northwest Ecuador) were stu...
Genetic factors can determine the high variability observed in response to lipid-lowering therapy w...